Press release
Erleada Market to Reach USD 7.77 Billion by 2036, Driven by Expanding Prostate Cancer Treatment Access and Clinical Adoption
Erleada Market
Get detailed market forecasts, competitive benchmarking, and pricing trends: https://www.factmr.com/connectus/sample?flag=S&rep_id=12240
Executive Summary & Stakeholder Insights
• Market valued at USD 3.30 billion (2025), rising to USD 3.57 billion (2026) and projected to reach USD 7.77 billion by 2036
• CAGR stands at 8.1% (2026-2036)
• Absolute dollar opportunity of USD 4.21 billion
• Erleada tablets lead product demand (2026) supported by clinical adoption and availability
• Non-metastatic castration-resistant prostate cancer dominates indication due to high patient volume
• First-line therapy leads treatment adoption driven by clinical protocol alignment
• Hospitals and oncology centers drive demand due to specialized treatment infrastructure
• Key market drivers:
o Increasing prostate cancer incidence and diagnosis rates
o Growing clinical evidence supporting efficacy and outcomes
o Expansion of payer coverage and reimbursement frameworks
o Rising investment in patient support programs and specialty pharmacy systems
• Market transformation:
o Shift toward targeted oncology therapies and precision treatment
o Growth in real-world evidence and clinical data utilization
o Expansion of global access across emerging healthcare markets
Comparative Data Insights
Global erleada market grows at 8.1% CAGR (2026-2036) supported by clinical adoption and market access
Japan records 10.1% CAGR driven by aging population and healthcare expansion
United States grows at 9.5% CAGR supported by strong payer coverage and specialty care access
China expands at 8.9% CAGR due to increasing diagnosis rates and reimbursement programs
Germany records 7.7% CAGR supported by structured pricing and healthcare systems
Brazil grows at 6.8% CAGR driven by expanding healthcare infrastructure
India reaches 6.3% CAGR supported by rising private healthcare investment
South Africa records 5.6% CAGR driven by private healthcare demand
Competitive Landscape & Entity Mapping
• Janssen Biotech, Inc. (80-85%)
o Dominates with ~82.4% market share and strong global Erleada portfolio leadership
• Zydus Lifesciences Limited (3-6%)
o Focuses on clinical expansion and emerging market access
• Pfizer Inc. (3-5%)
o Strengthens distribution partnerships and global reach
• Bayer AG (2-4%)
o Competes via oncology portfolio and treatment ecosystem
• Astellas Pharma Inc. (2-3%)
o Expands through regional oncology positioning
• Strategic positioning:
o Expansion of clinical evidence and indication coverage
o Strengthening payer negotiation and reimbursement access
o Investment in global distribution and specialty channels
Segment-Wise Performance
By Product
Erleada Tablets - Leading Segment (2026)
• Dominates due to established clinical use and broad availability
• Supported by physician familiarity and treatment protocols
By Indication
Non-Metastatic Castration-Resistant Prostate Cancer - Leading Segment
• Dominates due to high patient population and strong clinical data
• Drives core prescription demand
By Therapy Line
First-Line Therapy - Leading Segment
• Leads due to early treatment adoption and guideline alignment
• Supports long-term disease management
By End Use
Hospitals & Oncology Centers - Leading Segment
• Dominates due to specialized treatment infrastructure
• Drives prescription and administration volumes
By Distribution Channel
Hospital Pharmacies - Leading Channel
• Leads due to oncology drug dispensing and institutional supply systems
Review the Complete Industry Performance Analysis: https://www.factmr.com/report/erleada-market
Direct Q&A - Erleada Market
What is the projected size of the erleada market by 2036?
The market will reach USD 7.77 billion by 2036. Growth is driven by oncology demand.
What is the CAGR of the erleada market?
The market grows at a CAGR of 8.1% from 2026 to 2036. Expansion is steady.
Which company dominates the erleada market?
Janssen Biotech dominates with around 82.4% market share. Strong portfolio drives leadership.
Which indication drives the erleada market?
Non-metastatic castration-resistant prostate cancer leads demand. It has the largest patient base.
Which therapy line leads adoption in the erleada market?
First-line therapy leads adoption. Early treatment drives usage.
Browse the Most In-Demand Healthcare Market Studies: https://www.factmr.com/industry/healthcare
Unlock 360° insights for strategic decision making and investment planning: https://www.factmr.com/checkout/12240
To View Our Related Report:
Epistaxis Market: https://www.factmr.com/report/344/epistaxis-market
Tracheal Stents Market: https://www.factmr.com/report/tracheal-stents-market
3D Medical Imaging Devices Market: https://www.factmr.com/report/3d-medical-imaging-devices-market
Clinical Drainage Supplies Market: https://www.factmr.com/report/clinical-drainage-supplies-market
- Contact Us -
11140 Rockville Pike, Suite 400, Rockville,
MD 20852, United States
Tel: +1 (628) 251-1583 | sales@factmr.com
Fact.MR is a global market research and consulting firm, trusted by Fortune 500 companies and emerging businesses for reliable insights and strategic intelligence. With a presence across the U.S., UK, India, and Dubai, we deliver data-driven research and tailored consulting solutions across 30+ industries and 1,000+ markets. Backed by deep expertise and advanced analytics, Fact.MR helps organizations uncover opportunities, reduce risks, and make informed decisions for sustainable growth.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Erleada Market to Reach USD 7.77 Billion by 2036, Driven by Expanding Prostate Cancer Treatment Access and Clinical Adoption here
News-ID: 4539257 • Views: …
More Releases from Fact.MR
HBM for Defense and Space Computing Market is Projected to increase from USD 1.8 …
The global HBM for Defense and Space Computing Market reached USD 1.5 billion in 2025 and is projected to increase from USD 1.8 billion in 2026 to USD 9.0 billion by 2036, registering a compound annual growth rate (CAGR) of 17.4% from 2026 to 2036, according to Fact.MR.
Get Detailed Market Forecasts, Competitive Benchmarking, and Pricing Trends: https://www.factmr.com/connectus/sample?flag=S&rep_id=16012
The growing use of artificial intelligence and high-performance computing in defense and space…
HBM CoWoS Packaging Capacity and Supply Demand Market Will Hit USD 32.6 billion …
The global HBM CoWoS Packaging Capacity and Supply Demand Market reached USD 6.4 billion in 2025 and is projected to increase from USD 7.4 billion in 2026 to USD 32.6 billion by 2036, registering a compound annual growth rate (CAGR) of 16.0% from 2026 to 2036, according to Fact.MR.
Get Detailed Market Forecasts, Competitive Benchmarking, and Pricing Trends: https://www.factmr.com/connectus/sample?flag=S&rep_id=16008
The rapid expansion of artificial intelligence workloads is increasing demand for high-performance computing…
Agentic Artificial Intelligence Applications in Vector Database Market is Valued …
The global Agentic Artificial Intelligence Applications in Vector Database Market reached USD 2.3 billion in 2025 and is projected to increase from USD 2.8 billion in 2026 to USD 18.7 billion by 2036, registering a compound annual growth rate (CAGR) of 20.9% from 2026 to 2036, according to Fact.MR.
Get Detailed Market Forecasts, Competitive Benchmarking, and Pricing Trends: https://www.factmr.com/connectus/sample?flag=S&rep_id=16000
Agentic AI applications increasingly require systems capable of storing, retrieving, and interpreting high-dimensional…
AI Training Data Licensing & Royalty Brokerage Services Market Forecasted 31.1% …
The global AI Training Data Licensing and Royalty Brokerage Services Market surpassed USD 2.3 billion in 2025 and is projected to increase from USD 3.0 billion in 2026 to USD 45.0 billion by 2036, registering a compound annual growth rate (CAGR) of 31.1% from 2026 to 2036, according to Fact.MR. The transition from web scraping toward paid content access and structured royalty routing is creating significant demand for licensing and…
More Releases for CAGR
[CAGR of 6.7%] Nanocoatings Market Size, Industry Share, CAGR, Regional Forecast …
The global Nanocoatings Market generated $10.7 billion in 2020, and is projected to reach $20.1 billion by 2030, growing at a CAGR of 6.7% from 2021 to 2030. The report provides an in-depth analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive scenario, and wavering market trends.
Download sample PDF @ https://www.alliedmarketresearch.com/request-sample/2064
According to the report published by Allied Market Research,…
[CAGR of 5.3%] Pigments Market Size, Industry Share, CAGR, Regional Forecast, 20 …
A recent report by Allied Market Research provides a detailed analysis of the pigments market, highlighting its robust growth. The industry was valued at $27.2 billion in 2022 and is projected to surge to $45.4 billion by 2032, exhibiting an impressive CAGR of 5.3% from 2023 to 2032.
This research report identifies the growth drivers behind the market's expansion and delves into the market dynamics using advanced analytical frameworks…
Enzymes Market Expansion CAGR of 4.9% CAGR Anticipated 2025-2034
The Enzymes Market report is an in-depth examination of the global Enzymes Market's general consumption structure, development trends, sales techniques, and top nations' sales. The research looks at well-known providers in the global Enzymes Market industry, as well as market segmentation, competition, and the macroeconomic climate. A complete Enzymes Market analysis takes into account a number of aspects, including a country's population and business cycles, as well as market-specific microeconomic…
Waterproofing Membranes Market is Projected Grow at CAGR of 8% CAGR by 2033
The waterproofing membranes market is anticipated to witness a Compound Annual Growth Rate (CAGR) of 8.0% over the forecast period. By 2023, the estimated market value for waterproofing membranes is substantial, reaching US$ 31.5 billion.
These waterproofing materials comprise thin, impermeable membranes designed to collaborate with asphalt, providing a protective shield for the structural integrity of buildings. The asphalt component in these membranes acts as a safeguard, preserving the underlying membrane…
Electric Bed Market CAGR, Size, Share Grow USD 2,063 Million by 2030 CAGR 13.70%
Global electric bed market size is expected to be worth roughly USD 2,063 million by 2030, growing at a CAGR of more than 13.7% during the projected timeframe of 2022-2030, according to Ameco Research
A significant portion of the population over the age of 60, who often have reduced immunity levels and are more susceptible to neurological disorders, cardiac issues, tumors, and spinal cord compression, is anticipated to have a substantial…
Pediatric Radiology Market Size will Grow at CAGR 7.7% CAGR during 2017-2026
Pediatric Radiology Market:Overview
The pediatric radiology market is likely to register robust growth in the near future. Chronic illnesses among children including neurological disorders such as ADHD are on the rise. According to the US labor bureau, the demand for pediatrician is expected to grow by 24% on average by 2020. This is the highest average growth among all professionals in the United States.
Despite challenges such as training for new…
